Tuesday, March 5, 2024
HomeDr. Vinod L. Gaikwad

People

Quick Links

Notification Center

Dr. Vinod L. Gaikwad


Assistant Professor

Mobile:06224-277224

Email:drvinodg.niper@gmail.com

vinod.gaikwad@niperhajipur.ac.in

PhD Year:2014

Year of Joining:2021

WebPage: ORCID: https://orcid.org/0000-0002-3368-4467

Linkedin ID: https://in.linkedin.com/in/dr-vinod-l-gaikwad-59a97a22

Google Scholar ID: OdOYUhwAAAAJ&hl



Faculty CV

Distinctions

  • 96 percentile score (AIR-749) in “GATE 2006” examination conducted by IIT, Kharagpur.
  • “Certificate of Merit” for academic excellence from Bharati Vidyapeeth College of Pharmacy, Kolhapur (Dec 2008).
  • “Letter of Appreciation” from the Principal, Poona College of Pharmacy, Pune for work done at the Bharati Vidyapeeth (Deemed to be University), Pune (Oct 2021).
  • “Certificate of Appreciation” from the Chairman, AICTE, New Delhi for exceptional contribution as evaluator in “Toycathon, 2021” (Jan 2021).
  • “Letter of Appreciation” from the Chairman, Progressive Education Society, Pune for contribution in research (Dec 2015).
  • “Letter of Appreciation” from the Principal, College of Pharmacy, Pune for work done in Value Addition Program (Apr 2014).
  • “Certificate of Appreciation” from Event Coordinator / Principal of various institutes for talks delivered on different topics in National conference / seminar / workshops (90 talks).
  • Life member of APTI and Maharashtra State Pharmacy Council

Research Areas

  • Formulation development of conventional, modified, and targeted DDS
  • Computational modelling in formulation development & drug delivery
  • Novel manufacturing techniques
  • Solubility enhancement and particle engineering techniques

Book Chapters:

  • “Characterization of pharmaceutical nanocarriers: in vitro and in vivo studies” In: Grumezescu AM (Eds.), “Nanomaterials for Drug Delivery and Therapy” (ISBN: 978-0-12-816505-8). 2019; 33-58 (Publisher: Elsevier).
  • “Artificial intelligence (AI) in drug product designing, development, and manufacturing” In: Philip A, Shahiwala A, Rashid M, Faiyazuddin Md. (Eds), “A Handbook of Artificial Intelligence in Drug Delivery” (ISBN: 978-0-323-89925-3).2023; 395-442(Publisher: Elsevier).

Research Publications

  1. Understanding the influence of thermal cycles on the stability of metformin HCl in presence of Sitagliptin phosphate monohydrate and polyvinyl alcohol. Journal of Thermal Analysis and Calorimetry2023(Publisher: Springer Nature).
  2. Common Chemistry, Manufacturing, and Control Deficiencies in Abbreviated New Drug Applications Assessed by the US Food and Drug Administration: Hurdle to Access Cost-Effective Medicines. Journal of Pharmacological and Toxicological Methods2023; 123: 107295(Publisher: Elsevier).
  3. Artificial Intelligence in Pharmaceutical Regulatory Affairs. Drug Discovery Today2023;28(9): 103700(Publisher: Elsevier).
  4. Investigation of a biopolymer-based pH-responsive and sustained release raft-gel-forming tablet of famotidine: in-vitro, ex-vivo, bioavailability and anti-ulcer evaluation in New Zealand albino rabbit.Journal of Drug Delivery Science and Technology2023; 86: 104649(Publisher: Elsevier).
  5. Microwave-assisted grafting of Acrylamide on a natural Xylan gum for controlled drug delivery. Polymer Bulletin2023(Publisher: Springer Nature).
  6. Synthesis, characterization of chitosan nanoparticles decorated with folate and loaded with dasatinib for targeting folate receptors in cancer cells. OpenNano2022 (Publisher: Elsevier).
  7. An Overview of Regulations for Bioequivalence Assessment of Locally Acting Orally Inhaled Drug Products for the United States, Europe, Canada, and India. Expert Opinion on Drug Delivery2021; 18(12): 1843-1855. (Publisher: Taylor and Francis).
  8. Effect of polymers and process parameters in augmenting the compactability and dissolution behaviour of oxcarbazepine spherical agglomerates. Journal of Drug Delivery Science and Technology2021;64:1-8. (Publisher: Elsevier).
  9. Development of lipoprotein-drug conjugates for targeted drug delivery. Journal of Biomolecular Structure and Dynamics2021; 39(18): 6955-6973. (Publisher: Taylor and Francis).
  10. Comparative Pharmaceutical Evaluation of Variable Retail Priced Medicines Containing Biopharmaceutical Classification System Class-II or Class-IV Drugs. Indian Drugs 2021; 58(04):63-73. (Publisher: Indian Drug Manufacturers’ Association).
  11. QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl methylcellulose (Cellulose Ethers) Tablets Based on its Degree of Polymerization. AAPS PharmSciTech2019; 20:308. (Publisher: Springer).
  12. Regulatory Perspective of International Agencies for Development of Biosimilar Products (Monoclonal Antibodies): An Overview. Therapeutic Innovation and Regulatory Science2020; 54(5):965-977. (Publisher: SAGE).
  13. Quantitative Structure-Property Relationship Approach in Formulation Development: An Overview. AAPS PharmSciTech2019; 20(7): 268. (Publisher: Springer).
  14. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design. AAPS PharmSciTech2019; 20(5):192. (Publisher: Springer).
  15. Development of stability-indicating HPLC method and accelerated stability studies for osmotic and pulsatile tablet formulations of Clopidogrel Bisulfate. Journal of Pharmaceutical and Biomedical Analysis 2019; 165:346–356. (Publisher: Elsevier).
  16. Development of controlled release cellulose-pellets based multicore tablets. European Polymer Journal 2018; 105:389-397. (Publisher: Elsevier).
  17. Quantitative structure-property relationship modeling for prediction of hydrophilic drug entrapment in liposomes for lung targeted delivery. New Journal of Chemistry 2018; 42(6):4384-4393. (Publisher: Royal Society of Chemistry).
  18. Computational modeling of polymeric physicochemical properties for formulation development of a drug containing basic functionality. Journal of Pharmaceutical Sciences2017;106(11):3337-3345. (Publisher: Elsevier).
  19. Design and development of potent and selective factor IXa inhibitors. Journal of the Taiwan Institute of Chemical Engineers2016;68: 130-135. (Publisher: Elsevier).
  20. Statistical significance of polymeric physicochemical properties in the development of formulations containing a drug from neutral class. Arabian Journal of Chemistry2016;9(Supplement 2): S1915–S1927. (Publisher: Elsevier).
  21. Quantitative structure-property relationship modeling of excipient properties for prediction of formulation characteristics. Carbohydrate Polymers2016;151:593-599. (Publisher: Elsevier).
  22. Experimental and chemoinformatics evaluation of some physicochemical properties of excipients influencing release kinetics of the acidic drug ibuprofen. Chemosphere2015;138:494-502. (Publisher: Elsevier).
  23. Polymers influencing transportability profile of drug. Saudi Pharmaceutical Journal2013;21(4): 327-335. (Publisher: Elsevier).